These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16884312)

  • 1. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes.
    Tuccinardi T; Bertini S; Martinelli A; Minutolo F; Ortore G; Placanica G; Prota G; Rapposelli S; Carlson KE; Katzenellenbogen JA; Macchia M
    J Med Chem; 2006 Aug; 49(16):5001-12. PubMed ID: 16884312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.
    Minutolo F; Bellini R; Bertini S; Carboni I; Lapucci A; Pistolesi L; Prota G; Rapposelli S; Solati F; Tuccinardi T; Martinelli A; Stossi F; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
    J Med Chem; 2008 Mar; 51(5):1344-51. PubMed ID: 18269232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process.
    Minutolo F; Antonello M; Bertini S; Ortore G; Placanica G; Rapposelli S; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
    J Med Chem; 2003 Sep; 46(19):4032-42. PubMed ID: 12954056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of estrogen receptor-beta selective ligands.
    Manas ES; Unwalla RJ; Xu ZB; Malamas MS; Miller CP; Harris HA; Hsiao C; Akopian T; Hum WT; Malakian K; Wolfrom S; Bapat A; Bhat RA; Stahl ML; Somers WS; Alvarez JC
    J Am Chem Soc; 2004 Nov; 126(46):15106-19. PubMed ID: 15548008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
    Minutolo F; Bertini S; Granchi C; Marchitiello T; Prota G; Rapposelli S; Tuccinardi T; Martinelli A; Gunther JR; Carlson KE; Katzenellenbogen JA; Macchia M
    J Med Chem; 2009 Feb; 52(3):858-67. PubMed ID: 19128016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
    Wolohan P; Reichert DE
    J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of 17alpha-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain.
    Hanson RN; Lee CY; Friel CJ; Dilis R; Hughes A; DeSombre ER
    J Med Chem; 2003 Jul; 46(14):2865-76. PubMed ID: 12825929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives.
    Yang C; Edsall R; Harris HA; Zhang X; Manas ES; Mewshaw RE
    Bioorg Med Chem; 2004 May; 12(10):2553-70. PubMed ID: 15110838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Halleux C; Kallen J; Keller H; Schlaeppi JM; Stark W
    J Med Chem; 2003 Jul; 46(14):2945-57. PubMed ID: 12825935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
    Zeng J; Li W; Zhao Y; Liu G; Tang Y; Jiang H
    J Phys Chem B; 2008 Mar; 112(9):2719-26. PubMed ID: 18266357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity.
    Burendahl S; Danciulescu C; Nilsson L
    Proteins; 2009 Dec; 77(4):842-56. PubMed ID: 19626711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists.
    Sun W; Cama LD; Birzin ET; Warrier S; Locco L; Mosley R; Hammond ML; Rohrer SP
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1468-72. PubMed ID: 16412638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and beta.
    Minutolo F; Antonello M; Bertini S; Rapposelli S; Rossello A; Sheng S; Carlson KE; Katzenellenbogen JA; Macchia M
    Bioorg Med Chem; 2003 Apr; 11(7):1247-57. PubMed ID: 12628652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New computational strategy to analyze the interactions of ERalpha and ERbeta with different ERE sequences.
    Marabotti A; Colonna G; Facchiano A
    J Comput Chem; 2007 Apr; 28(6):1031-41. PubMed ID: 17269124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.
    Shen J; Li W; Liu G; Tang Y; Jiang H
    J Phys Chem B; 2009 Jul; 113(30):10436-44. PubMed ID: 19583238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
    Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
    J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERbeta ligands. Part 5: synthesis and structure-activity relationships of a series of 4'-hydroxyphenyl-aryl-carbaldehyde oxime derivatives.
    Mewshaw RE; Bowen SM; Harris HA; Xu ZB; Manas ES; Cohn ST
    Bioorg Med Chem Lett; 2007 Feb; 17(4):902-6. PubMed ID: 17188490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New scaffolds for the design of selective estrogen receptor modulators.
    Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
    Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.